Currault Douglas N. II reported option exercise involving 15,000 derivative units of FREEPORT-MCMORAN INC at $0.00 for $0 on Aug 25, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
EVP & General Counsel
EVP & General Counsel
Filed Aug 26, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
15,000Options (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Aug 25, 2026Option exercise
Filed
Aug 26, 2026, 5:24 PM ET1-day reporting delay
Accession
0001214659-26-010926Code M · Transaction 103136
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 25, 2026Option exercise65,000$0.00$0Trade 103135
Aug 25, 2026Sell80,000$78.56−$6,284,464Trade 103134
Aug 25, 2026Option exercise65,000$12.04$782,600Trade 103132
Aug 25, 2026Option exercise15,000$28.14$422,100Trade 103133
5 transaction rows in this filing. Joint filers share the same rows.

FCX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
FCX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −21%1w ago −16%1d ago −1.5%
Returns since7d −6.4%30d −8.5%90d180d1y

Footnotes in full

F1: The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $78.5500 - $78.5950. The Reporting Person here undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. F2: Options granted were 33% exercisable on the date indicated and 33% exercisable on each of the next two anniversaries thereof. F3: Options granted were 33% exercisable on the date indicated and 33% exercisable on each of the next two anniversaries thereof. F4: Amount beneficially owned includes 36,499 Common Stock Restricted Stock Units.